SCM Lifescience, Yozma in MOU to develop stem cell therapies

SCM Lifescience (Incheon, South Korea) and Yozma Bio Science Holdings (Seoul,

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE